CPS by CPhA vs iCCS

CPS (formerly RxTx) has a new appearance. CPS is still the reliable, evidence-based drug resource it has always been and provides essential drug information at the point-of-care for health care practitioners. Now offering two subscription options – CPS Drug Information or CPS Full Access. CPS Drug Information is the Canadian standard for drug monographs, containing thousands of products including monographs for drugs, vaccines, natural health products and medical devices, approved by Health Canada. CPS Full Access includes all content from CPS Drug Information and the most current, evidence-based therapeutic information and non-prescription therapy for most common conditions, with cross-referenced drug tables and algorithms and DC condition-based drug tables. Both subscriptions types provide critical updates such as warnings and advisories; and useful tools such as medical calculators.

The iCCS app provides users with top CCS Guidelines. Read and use CCS Guidelines in practice, for teaching, and self-guided learning. Click on a topic in the app to view the table of contents, then navigate by chapter and section. iCCS includes Guidelines on: - Fitness to Drive (2023) - Peripheral Arterial Disease (2022)  - Cardiorenal Risk Reduction (2022)  - Heart Failure (2017, 2020, 2021)  - Dyslipidemia (2021)  - Atrial Fibrillation (2020)  Visit www.ccs.ca/guidelines for many more Guidelines, Clinical Practice Updates, clinical decision support tools and resources including infographics, educational webinars, slide sets and pocket guides.